Skip to nav Skip to content

Physicians looking to refer a patient to experienced malignant hematology specialists can consider the many advantages of receiving treatment at Moffitt Cancer Center. Led by Jeffrey Lancet, MD, the team that makes up our Malignant Hematology Program focuses exclusively on the diagnosis and treatment of different blood cancers and autoimmune disorders. Our program’s survival rates are better than the national averages, and as a high-volume cancer center, our malignant hematology specialists have a unique level of experience treating patients with conditions like:

  • Leukemia
  • Lymphoma
  • Myelodysplastic syndromes (MDS)
  • Myeloproliferative syndromes
  • Multiple myeloma
  • Aplastic anemia
  • Other hematological malignancies

Individualized treatment plans from our malignant hematology specialists

When a patient is referred to Moffitt, we will provide a complete diagnostic workup, including staging and pathology services, to get a full picture of the patient’s condition. Then, our malignant hematology specialists – including medical oncologists, hematopathologists and others – will review his or her case to ensure we provide an individualized treatment plan that will give the patient the best chance at reaching a favorable outcome and an improved quality of life. Depending on the specifics of a patient’s malignancy, a treatment plan may consist of a combination of the following:

  • Chemotherapy
  • Immunotherapy
  • Bone marrow transplantation
  • Anti-angiogenesis therapy
  • Promising clinical trials for eligible patients

At Moffitt, our focus extends beyond clinical treatment. We also tend to our patients’ quality of life. That’s why our patients have access to pain management specialists, dietitians, counselors and other supportive care professionals to help them cope with the challenges of undergoing cancer treatment.

Moffitt welcomes referrals for patients with a confirmed diagnosis as well as those with suspected hematologic conditions. To refer a patient to the malignant hematology specialists at Moffitt, health care providers can complete our online form or contact a physician liaison for assistance or support. We aim to make referral times as short as possible.

 

 

  • Malignant Hematology Leadership
    Jeffrey  Lancet, MD
    Department Chair, Malignant Hematology
    Program Lead, Malignant Hematology

    Program

    Malignant Hematology

    Title

    Chair, Department of Malignant Hematology

    Specialty

    Hematology

    4.9 (139)
    Rami  Komrokji, MD

    Program

    Malignant Hematology

    Title

    Vice Chair, Department of Malignant Hematology

    Specialty

    Hematology/Oncology

    4.9 (203)
  • Medical Oncology
    Julio  Chavez, MD, MS

    Program

    Malignant Hematology

    Specialty

    Medical Oncology

    4.9 (200)
    Hugo  Fernandez, MD
    Department Chair, Malignant Hematology and Cellular Therapy at Memorial Healthcare System
    Program Lead, Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Program

    Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Title

    Chair, Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Specialty

    Medical Oncology

    Sameh  Gaballa, MD

    Program

    Malignant Hematology

    Specialty

    Medical Oncology

    4.9 (184)
    Eric  Padron, MD

    Program

    Malignant Hematology

    Specialty

    Medical Oncology

    4.9 (103)
    Ken  Shain, MD, PhD

    Program

    Malignant Hematology

    Specialty

    Medical Oncology

    4.9 (203)
    Kendra  Sweet, MD

    Program

    Malignant Hematology

    Specialty

    Medical Oncology

    5 (46)
  • Hematology
    Jeffrey  Lancet, MD
    Department Chair, Malignant Hematology
    Program Lead, Malignant Hematology

    Program

    Malignant Hematology

    Title

    Chair, Department of Malignant Hematology

    Specialty

    Hematology

    4.9 (139)